Krka dd Novo Mesto

Krka dd Novo Mesto maintains a strong liquidity position, with a current ratio of 3.96, indicating the company can cover its short-term liabilities more than three times over. The company's liquidity_fpt score suggests a medium liquidity risk, which is consistent with its low long-term debt of EUR 18.36 million and a debt-to-equity ratio of 0.01, reflecting a conservative capital structure. In terms of profitability, Krka dd Novo Mesto reports a return on equity (ROE) of 17.1% and a return on assets (ROA) of 13.25%, both of which exceed the typical thresholds for the pharmaceutical industry. These metrics suggest the company is effectively utilizing its equity and assets to generate returns. The company's revenue is primarily concentrated in its domestic market and Central and Eastern Europe, with no disclosed segment or geographic breakdown in the latest financials. This concentration may expose the company to regional economic and regulatory risks, though the lack of detailed segment data limits the ability to assess this risk precisely. Krka dd Novo Mesto has demonstrated consistent revenue growth, with a total revenue of EUR 2.04 billion in the latest reporting period. While no specific growth rate is provided, the company's operating cash flow of EUR 528.62 million and free cash flow of EUR 146.87 million suggest strong cash generation capabilities, which support its growth trajectory. The company's risk assessment indicates a low dilution risk, with no significant dilution potential identified in the basic shares outstanding. However, the risk assessment also notes that net cash is negative after subtracting total debt, which could signal potential liquidity constraints if not managed carefully. There are no recent events or filings specifically mentioned in the provided data that would indicate significant changes in the company's operations or financial position. The absence of recent transcripts or filings does not suggest immediate operational or financial distress, but it also limits the ability to assess recent developments.